(Q35023680)

5 August 2017

title

Meeting the societal need for new antibiotics: the challenges for the pharmaceutical industry (English)

1 reference

5 August 2017

Seamus O'Brien

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 February 2015

1 reference

British Journal of Clinical Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

79

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

168-172

1 reference

Antibiotic resistance-the need for global solutions

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Platforms for antibiotic discovery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Is the GAIN Act a turning point in new antibiotic discovery?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

The critical impact of time discounting on economic incentives to overcome the antibiotic market failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.12401

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4309623

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

25 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.12401

21 January 2018

Identifiers

DOI

10.1111/BCP.12401

1 reference

5 August 2017

1 reference

5 August 2017

1 reference